Unsuccessful fertility treatment takes a toll on both partners, and knowing their mental health history can help predict depression risk.
An intensive in-home program aimed at pregnant teens at risk for drug use and depression, specifically American Indian teens, proves successful.
More than a third of women consider ob/gyns their primary care providers. To better meet the needs of their patients, one ob/gyn clinic offered different treatments for depression and compared the results.
Antidepressant use in pregnancy increases the risk of preterm birth. However, untreated depression is serious, and the needs of the mother must come first.
Depression over an extended period may make it more difficult for women to get pregnant.
Many choose to discontinue antidepressant treatment during attempts to conceive or during pregnancy, in spite of the risks of untreated perinatal depression. Safety profiles of antidepressant use during pregnancy are increasingly being studied, and many women seek alternatives during pregnancy. This article will review several complementary and alternative (CAM) treatments for prenatal unipolar depression: omega-3 fatty acids, folate, St John’s Wort, bright light therapy, massage therapy, and exercise.
Fish oil supplementation that is rich in omega-3 fatty acids does not prevent depressive symptoms during pregnancy or in the postpartum period, according to the results of a double-blind, randomized controlled trial.
There is no association between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and stillbirth, neonatal mortality, and infant growth rate during the first year of life, according to the results of 2 unrelated studies.
Nurse-delivered interventions that combined psychoeducation with supportive attention may help improve mood in patients in whom cancer has been newly diagnosed.
For women undergoing fertility treatments, the use of selective serotonin reuptake inhibitors use may decrease pregnancy rates and increase miscarriage rates.